SteadySharesSteadyShares
The market
MarketsDiscover
Follow the money
Smart MoneyPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in to save your work
Closed
SteadySharesMarketsDiscoverSmart MoneyMy WealthPoliticiansCryptoNews
/
Discover4543.T
HealthcareTokyoJPY

Terumo

¥00123456789,001234567890012345678900123456789.0012345678900123456789+0.3%
52w low (est.) ¥1,866.53¥2,773.62 52w high (est.)
Peers
Market data
Market cap
¥3.23T
52-week range
¥1,900.00 – ¥2,818.00
Beta (vs market)
0.23
Sector
Healthcare
Valuation
P/E ratio
23.8x
DCF fair value
¥3,548.16
Margin of safety
+57.5%
Forward P/E
21.5x
PEG ratio
2.18
Dividend yield
1.64%
Quality & efficiency
Moat score
70/100
Return on equity
9.2%
Profit margin
12.0%
Debt / equity
0.27
Growth & analysts
Revenue growth (YoY)
+13.8%
Analyst target
¥2,961.54
Target upside
+31.5%
Analysts covering
13

About Terumo

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through four segments: Cardiac and Vascular Company, Medical Care Solutions Company, Blood and Cell Technologies Company, and Terumo Organ Technologies. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular stent grafts, and others. The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management adhesion barriers, and others; blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others. The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others. The Terumo Organ Technologies segment provides organ preservation devices. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was incorporated in 1921 and is headquartered in Shibuya, Japan.

Valuation

ValueGrowthProfitHealthIncome61QUALITY
Overall Rating
76
Strong Buy
Strong Buy
Moat Score70
DCF Intrinsic Value
¥3,548.16+57.5% upside

Moat, DCF and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
¥3.23T
P/E Ratio
23.8
Dividend Yield
1.64%
Revenue Growth
+13.8%
Profit Margin
12.0%
ROE
9.2%
Debt / Equity
0.27
Beta
0.23
vs Healthcare sector:P/E 24 vs 28 · cheaperMoat 70 vs 7Yield 1.64% vs 0.3%

Statistics

Similar Stocks · Healthcare

LLY73
$920.00+0.7%
AZN.L72
£105.20+0.6%
UNH71
$492.10+1.6%
JNJ70
$146.20-0.2%

Latest News · 4543.T